CXSE
1 tracked call · 1 long · 0 short
first called by All-In Podcast 6mo ago
LONG6mo ago
“In 2022, Chinese companies were just 5% of licensing deals... 2025, 42%. And recently, one of the biggest licensing deals ever was 3S Bio, $1.25 billion…”All-In Podcast
US-China biotech race: China taking share of licensing deals fast; reform tries to defend US life-sciences lead
CXSELONG@ $41.63
$37.73-9.37%
since call Jan 15